Commentary

Article

Top 5 Pharmacy Times Videos of 2023

From newsworthy moments to groundbreaking research, these were the most watched videos on Pharmacy Focus in 2023.

1. Opioid Drug Shortages Affect Patients, Health Systems

Pharmacists are experts at juggling shortages of all kinds, however, and Alfred L’Altrelli, PharmD, CFMC, MBA, senior director of pharmacy at UPMC Presbyterian-Shadyside, said they are crucial team members regarding opioid access challenges. Watch Here.

2. Estrogen Impacts the Effects of Psilocybin for Women

Jennifer Chesak, author of The Psilocybin Handbook for Women, discusses how estrogen can affect binding at the serotonin receptor sites, causing psilocybin to impact women’s bodies differently. Watch Here.

3. Sublingual Vaccine Shows Efficacy in Preventing Recurrent UTIs, Helping to Eliminate Need for Antibiotics

Women with recurrent urinary tract infections (UTIs) are often on and off antibiotics for years, and even decades, as the only treatment available in health systems for treating UTIs. Watch Here.

4. Signs and Symptoms of Pneumococcal Infections

Medical experts provide an overview of the signs and symptoms of pneumococcal infections. Watch Here.

5. AmerisourceBergen Corporate Partnerships Team Aims to Support, Guide Pharmacy Customers

Claire Biermaas, president of Corporate Partnerships at AmerisourceBergen, discusses the Corporate Partnerships Team, which works closely with pharmacy customers to guide their processes and help execute their vision. Watch Here.

Related Videos
Senior Doctor is examining An Asian patient.
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix